170 related articles for article (PubMed ID: 12673364)
1. TP53 and mutations in human cancer.
Szymańska K; Hainaut P
Acta Biochim Pol; 2003; 50(1):231-8. PubMed ID: 12673364
[TBL] [Abstract][Full Text] [Related]
2. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.
de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P
Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
5. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A; Achatz MI; Borresen-Dale AL; Hainaut P; Olivier M
Oncogene; 2007 Apr; 26(15):2157-65. PubMed ID: 17401424
[TBL] [Abstract][Full Text] [Related]
7. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
[TBL] [Abstract][Full Text] [Related]
8. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
[TBL] [Abstract][Full Text] [Related]
10. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
11. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.
Bumroongkit K; Rannala B; Traisathit P; Srikummool M; Wongchai Y; Kangwanpong D
Cancer Genet Cytogenet; 2008 Aug; 185(1):20-7. PubMed ID: 18656689
[TBL] [Abstract][Full Text] [Related]
12. Profile of TP53 gene mutations in sinonasal cancer.
Holmila R; Bornholdt J; Suitiala T; Cyr D; Dictor M; Steiniche T; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
Mutat Res; 2010 Apr; 686(1-2):9-14. PubMed ID: 20025891
[TBL] [Abstract][Full Text] [Related]
13. TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis.
Olivier M; Hainaut P
Semin Cancer Biol; 2001 Oct; 11(5):353-60. PubMed ID: 11562177
[TBL] [Abstract][Full Text] [Related]
14. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
15. Loss of TP53-DNA interaction induced by p.C135R in lung cancer.
Aranda M; Gonzalez-Nilo F; Riadi G; Díaz V; Perez J; Martel G; Hainaut P; Mimbacas A
Oncol Rep; 2007 Nov; 18(5):1213-7. PubMed ID: 17914575
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC
Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of tumor suppressor gemne TP53 in tobacco smoke-associated tumors].
Szyfter K; Kiwerska K; Rydzanicz M; Kruszyna Ł; Zemleduch T; Jagodziński P
Przegl Lek; 2009; 66(10):603-7. PubMed ID: 20301891
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
Katiyar S; Hedau S; Jain N; Kar P; Khuroo MS; Mohanta J; Kumar S; Gopalkrishna V; Kumar N; Das BC
Cancer Lett; 2005 Jan; 218(1):69-79. PubMed ID: 15639342
[TBL] [Abstract][Full Text] [Related]
19. Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma.
Leitao MM; Soslow RA; Baergen RN; Olvera N; Arroyo C; Boyd J
Gynecol Oncol; 2004 May; 93(2):301-6. PubMed ID: 15099937
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries.
Egashira A; Morita M; Kakeji Y; Sadanaga N; Oki E; Honbo T; Ohta M; Maehara Y
Cancer Sci; 2007 Aug; 98(8):1152-6. PubMed ID: 17573896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
